Page last updated: 2024-08-18

proflavine and ciprofloxacin

proflavine has been researched along with ciprofloxacin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW1
Anderson, KC; Kellogg, GE; Sarkar, A1
Nikaido, H; Su, CC; Yu, EW1
Klesius, PH; Pridgeon, JW; Yildirim-Aksoy, M1

Other Studies

4 other study(ies) available for proflavine and ciprofloxacin

ArticleYear
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin

2008
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
    European journal of medicinal chemistry, 2012, Volume: 52

    Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics

2012
Ligand-transporter interaction in the AcrB multidrug efflux pump determined by fluorescence polarization assay.
    FEBS letters, 2007, Oct-16, Volume: 581, Issue:25

    Topics: Ciprofloxacin; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Hydrogen-Ion Concentration; Kinetics; Ligands; Multidrug Resistance-Associated Proteins; Proflavine

2007
Attempt to develop live attenuated bacterial vaccines by selecting resistance to gossypol, proflavine hemisulfate, novobiocin, or ciprofloxacin.
    Vaccine, 2013, Apr-26, Volume: 31, Issue:18

    Topics: Aeromonas hydrophila; Animals; Bacterial Vaccines; Ciprofloxacin; Drug Resistance, Bacterial; Edwardsiella tarda; Fish Diseases; Gossypol; Ictaluridae; Novobiocin; Proflavine; Streptococcus; Tilapia; Vaccines, Attenuated; Virulence

2013